glp-1 pen Do the new “slimming” drugs deliver better pouch performance? - J Pouch support charity It's time to have a

doi: 10.1079/bjn20041225 [DOI] [PubMed] [Google Scholar] 97

If you are a female of reproductive potential: Zepbound may reduce the efficacy of oral hormonal contraceptives

This ensures the plan continues to work for you and can be adjusted if needed

Avoid Sudden Head Movements: Rapidly turning your head or bending over to pick something up can trigger lightheadedness

With the caveat that this case series includes only four cases, it appears that narrower optic nerve heads may pose a greater risk for semaglutide-associated NAION, potentially independent of systemic risk factors

The Danish company Novo Nordisk sells several different brand names with semaglutide as an active ingredient: notably, Ozempic, for diabetes and reducing cardiovascular event risks, and Wegovy, for weight loss and reducing cardiovascular event risks